Report Detail
COVID-19 Impact on Global Artemisinine Market Insights, Forecast to 2026
- RnM4041462 |
- 15 June, 2020 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Artemisinine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Artemisinine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Artemisinine market is segmented into
Extraction from Artemisia annua
Semisynthetic Artemisinine
Segment by Application, the Artemisinine market is segmented into
Injections
Tablets
Others
Regional and Country-level Analysis
The Artemisinine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Artemisinine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Artemisinine Market Share Analysis
Artemisinine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Artemisinine business, the date to enter into the Artemisinine market, Artemisinine product introduction, recent developments, etc.
The major vendors covered:
Guilin Pharmaceutical
CAT KHANH
Novanat Bioresource
BEEPZ
KPC Pharmaceuticals
BIONEXX
Guangxi xiancaotang
Sanofi
Natural Bio-engineering
Kerui nanhai
1 Study Coverage
- 1.1 Artemisinine Product Introduction
- 1.2 Market Segments
- 1.3 Key Artemisinine Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Artemisinine Market Size Growth Rate by Type
- 1.4.2 Extraction from Artemisia annua
- 1.4.3 Semisynthetic Artemisinine
- 1.5 Market by Application
- 1.5.1 Global Artemisinine Market Size Growth Rate by Application
- 1.5.2 Injections
- 1.5.3 Tablets
- 1.5.4 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Artemisinine Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Artemisinine Industry
- 1.6.1.1 Artemisinine Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Artemisinine Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Artemisinine Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Artemisinine Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Artemisinine Market Size Estimates and Forecasts
- 2.1.1 Global Artemisinine Revenue 2015-2026
- 2.1.2 Global Artemisinine Sales 2015-2026
- 2.2 Artemisinine Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Artemisinine Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Artemisinine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Artemisinine Competitor Landscape by Players
- 3.1 Artemisinine Sales by Manufacturers
- 3.1.1 Artemisinine Sales by Manufacturers (2015-2020)
- 3.1.2 Artemisinine Sales Market Share by Manufacturers (2015-2020)
- 3.2 Artemisinine Revenue by Manufacturers
- 3.2.1 Artemisinine Revenue by Manufacturers (2015-2020)
- 3.2.2 Artemisinine Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Artemisinine Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Artemisinine Revenue in 2019
- 3.2.5 Global Artemisinine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Artemisinine Price by Manufacturers
- 3.4 Artemisinine Manufacturing Base Distribution, Product Types
- 3.4.1 Artemisinine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Artemisinine Product Type
- 3.4.3 Date of International Manufacturers Enter into Artemisinine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Artemisinine Market Size by Type (2015-2020)
- 4.1.1 Global Artemisinine Sales by Type (2015-2020)
- 4.1.2 Global Artemisinine Revenue by Type (2015-2020)
- 4.1.3 Artemisinine Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Artemisinine Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Artemisinine Sales Forecast by Type (2021-2026)
- 4.2.2 Global Artemisinine Revenue Forecast by Type (2021-2026)
- 4.2.3 Artemisinine Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Artemisinine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Artemisinine Market Size by Application (2015-2020)
- 5.1.1 Global Artemisinine Sales by Application (2015-2020)
- 5.1.2 Global Artemisinine Revenue by Application (2015-2020)
- 5.1.3 Artemisinine Price by Application (2015-2020)
- 5.2 Artemisinine Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Artemisinine Sales Forecast by Application (2021-2026)
- 5.2.2 Global Artemisinine Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Artemisinine Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Artemisinine by Country
- 6.1.1 North America Artemisinine Sales by Country
- 6.1.2 North America Artemisinine Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Artemisinine Market Facts & Figures by Type
- 6.3 North America Artemisinine Market Facts & Figures by Application
7 Europe
- 7.1 Europe Artemisinine by Country
- 7.1.1 Europe Artemisinine Sales by Country
- 7.1.2 Europe Artemisinine Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Artemisinine Market Facts & Figures by Type
- 7.3 Europe Artemisinine Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Artemisinine by Region
- 8.1.1 Asia Pacific Artemisinine Sales by Region
- 8.1.2 Asia Pacific Artemisinine Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Artemisinine Market Facts & Figures by Type
- 8.3 Asia Pacific Artemisinine Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Artemisinine by Country
- 9.1.1 Latin America Artemisinine Sales by Country
- 9.1.2 Latin America Artemisinine Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Artemisinine Market Facts & Figures by Type
- 9.3 Central & South America Artemisinine Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Artemisinine by Country
- 10.1.1 Middle East and Africa Artemisinine Sales by Country
- 10.1.2 Middle East and Africa Artemisinine Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Artemisinine Market Facts & Figures by Type
- 10.3 Middle East and Africa Artemisinine Market Facts & Figures by Application
11 Company Profiles
- 11.1 Guilin Pharmaceutical
- 11.1.1 Guilin Pharmaceutical Corporation Information
- 11.1.2 Guilin Pharmaceutical Description, Business Overview and Total Revenue
- 11.1.3 Guilin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Guilin Pharmaceutical Artemisinine Products Offered
- 11.1.5 Guilin Pharmaceutical Recent Development
- 11.2 CAT KHANH
- 11.2.1 CAT KHANH Corporation Information
- 11.2.2 CAT KHANH Description, Business Overview and Total Revenue
- 11.2.3 CAT KHANH Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 CAT KHANH Artemisinine Products Offered
- 11.2.5 CAT KHANH Recent Development
- 11.3 Novanat Bioresource
- 11.3.1 Novanat Bioresource Corporation Information
- 11.3.2 Novanat Bioresource Description, Business Overview and Total Revenue
- 11.3.3 Novanat Bioresource Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Novanat Bioresource Artemisinine Products Offered
- 11.3.5 Novanat Bioresource Recent Development
- 11.4 BEEPZ
- 11.4.1 BEEPZ Corporation Information
- 11.4.2 BEEPZ Description, Business Overview and Total Revenue
- 11.4.3 BEEPZ Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 BEEPZ Artemisinine Products Offered
- 11.4.5 BEEPZ Recent Development
- 11.5 KPC Pharmaceuticals
- 11.5.1 KPC Pharmaceuticals Corporation Information
- 11.5.2 KPC Pharmaceuticals Description, Business Overview and Total Revenue
- 11.5.3 KPC Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 KPC Pharmaceuticals Artemisinine Products Offered
- 11.5.5 KPC Pharmaceuticals Recent Development
- 11.6 BIONEXX
- 11.6.1 BIONEXX Corporation Information
- 11.6.2 BIONEXX Description, Business Overview and Total Revenue
- 11.6.3 BIONEXX Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 BIONEXX Artemisinine Products Offered
- 11.6.5 BIONEXX Recent Development
- 11.7 Guangxi xiancaotang
- 11.7.1 Guangxi xiancaotang Corporation Information
- 11.7.2 Guangxi xiancaotang Description, Business Overview and Total Revenue
- 11.7.3 Guangxi xiancaotang Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Guangxi xiancaotang Artemisinine Products Offered
- 11.7.5 Guangxi xiancaotang Recent Development
- 11.8 Sanofi
- 11.8.1 Sanofi Corporation Information
- 11.8.2 Sanofi Description, Business Overview and Total Revenue
- 11.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Sanofi Artemisinine Products Offered
- 11.8.5 Sanofi Recent Development
- 11.9 Natural Bio-engineering
- 11.9.1 Natural Bio-engineering Corporation Information
- 11.9.2 Natural Bio-engineering Description, Business Overview and Total Revenue
- 11.9.3 Natural Bio-engineering Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Natural Bio-engineering Artemisinine Products Offered
- 11.9.5 Natural Bio-engineering Recent Development
- 11.10 Kerui nanhai
- 11.10.1 Kerui nanhai Corporation Information
- 11.10.2 Kerui nanhai Description, Business Overview and Total Revenue
- 11.10.3 Kerui nanhai Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Kerui nanhai Artemisinine Products Offered
- 11.10.5 Kerui nanhai Recent Development
- 11.1 Guilin Pharmaceutical
- 11.1.1 Guilin Pharmaceutical Corporation Information
- 11.1.2 Guilin Pharmaceutical Description, Business Overview and Total Revenue
- 11.1.3 Guilin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Guilin Pharmaceutical Artemisinine Products Offered
- 11.1.5 Guilin Pharmaceutical Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Artemisinine Market Estimates and Projections by Region
- 12.1.1 Global Artemisinine Sales Forecast by Regions 2021-2026
- 12.1.2 Global Artemisinine Revenue Forecast by Regions 2021-2026
- 12.2 North America Artemisinine Market Size Forecast (2021-2026)
- 12.2.1 North America: Artemisinine Sales Forecast (2021-2026)
- 12.2.2 North America: Artemisinine Revenue Forecast (2021-2026)
- 12.2.3 North America: Artemisinine Market Size Forecast by Country (2021-2026)
- 12.3 Europe Artemisinine Market Size Forecast (2021-2026)
- 12.3.1 Europe: Artemisinine Sales Forecast (2021-2026)
- 12.3.2 Europe: Artemisinine Revenue Forecast (2021-2026)
- 12.3.3 Europe: Artemisinine Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Artemisinine Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Artemisinine Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Artemisinine Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Artemisinine Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Artemisinine Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Artemisinine Sales Forecast (2021-2026)
- 12.5.2 Latin America: Artemisinine Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Artemisinine Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Artemisinine Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Artemisinine Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Artemisinine Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Artemisinine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Artemisinine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Artemisinine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Artemisinine. Industry analysis & Market Report on COVID-19 Impact on Global Artemisinine is a syndicated market report, published as COVID-19 Impact on Global Artemisinine Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Artemisinine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
